September 8th, 2014
Selections from Richard Lehman’s Literature Review: September 8th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the PARADIGM-HF trial, sham controls in medical-device trials, the efficacy of β blockers in patients with heart failure and atrial fibrillation, and more.
May 27th, 2014
Selections from Richard Lehman’s Literature Review: May 27th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include mortality trends in patients with diabetes, cardiovascular remodeling in CAD and HF, and more.
August 5th, 2013
Selections from Richard Lehman’s Literature Review: August 5th
Richard Lehman, BM, BCh, MRCGP
This week’s topic is an association between severe hypoglycemia and an approximate doubling of CV events in patients with type 2 diabetes.
July 29th, 2013
Selections from Richard Lehman’s Literature Review: July 29th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include riociguat for chronic thromboembolic pulmonary hypertension, renal outcomes associated with invasive vs. conservative management of ACS, statins and musculoskeletal conditions, arthropathies, and injuries, and more.
October 8th, 2010
Analysis of ADVANCE Explores Role of Hypoglycemia
Larry Husten, PHD
A new analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation) trial sheds light on the role of hypoglycemia in recent trials of glucose control. In a paper in the New England Journal of Medicine, the ADVANCE investigators report that 2.1% of 11,140 patients with type 2 diabetes […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?